[Asia Economy Reporter Lee Myunghwan] CKH announced on the 7th that it has decided to lend 20,478,150,000 KRW to its subsidiary, Fukken Kumsan Daedo Health Science Group Co., Ltd. This amount corresponds to 18.6% of its equity capital.



This lending decision is an extension of the existing loan amount and is intended as a loan for operating funds.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing